Author Archives: Magdalena Kegel

Transcranial Magnetic Stimulation Ineffective for Depression in Parkinson’s, Study Reports

Repetitive transcranial magnetic stimulation (TMS) does not appear to treat depressive symptoms in patients with Parkinson’s disease, although it may improve motor symptoms, an analysis of nine clinical trials found. But the study included relatively few patients, so the researchers, with Guangxi University of Science and Technology in China, said that their conclusions warrant further exploration…

Top 10 Parkinson’s Disease Stories of 2017

Throughout the past year, Parkinson’s News Today has brought you news on Parkinson’s disease treatment development, clinical trials, research, and events. As we look forward to bringing you more news in 2018, we would like to sum up 2017 by bringing you the Top 10 Parkinson’s disease stories that…

Parkinson’s Protein Aggregates Seen in Action Destroying Neurons in Brain

Researchers have uncovered how aggregates of the Parkinson’s disease-associated protein alpha-synuclein damages nerve cells. The discovery offers scientists a road map to strategies for developing new treatments for the disease. The study is also a breakthrough in Parkinson’s research. Even though researchers have long known that alpha-synuclein protein…

Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment

In an unexpected finding, researchers demonstrated that certain asthma drugs might protect from developing Parkinson’s disease by lowering the production of the disease-linked protein alpha-synuclein. But researchers caution against attempting to medicate with such drugs before clinical trials establish they are safe in this patient group, and that they really…